← Back to Search

Crisis Line Support for Suicide Prevention in Alcoholism

N/A

Recruiting

Led By Mark Ilgen, PhD

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Patients who do not understand English

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing whether a therapy session about thoughts and perceptions of the National Suicide Prevention Lifeline could help people who have experienced a suicidal crisis.

Who is the study for?

This trial is for individuals with a probable alcohol use disorder in the past year, indicated by an AUDIT score of 16 or more. Participants must have attempted suicide within the last year or had suicidal thoughts recently, as shown by certain scores on the Beck scales.

What is being tested?

The study is testing whether therapy sessions discussing perceptions about using the National Suicide Prevention Lifeline can benefit those who've faced a suicidal crisis and have issues with alcohol.

What are the potential side effects?

Since this trial involves therapy sessions rather than medication, traditional side effects are not expected. However, participants may experience emotional distress when discussing sensitive topics like suicide.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not understand English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Crisis line utilization

Secondary study objectives

Suicidal behavior

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Crisis Line Facilitation (CLF)Experimental Treatment1 Intervention

This single-session intervention addresses the individuals' perceived barriers and facilitators of crisis line use during periods of suicidal crisis.

Group II: Enhanced Usual Care (EUC)Active Control1 Intervention

Participants randomized to the EUC condition will receive a brochure (in-person, via email, or via text message) with the NSP Lifeline and a list of outpatient mental health and substance use resources and encouraged to schedule an appointment with a clinical provider if they would like to discuss any current or past symptoms.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Crisis Line Facilitation (CLF)

2016

N/A

~310

0 / 1Eligibility criteria met